These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 8428923
1. Initial interaction between fibrin and tissue plasminogen activator (t-PA). The Gly-Pro-Arg-Pro binding site on fibrin(ogen) is important for t-PA activity. Kaczmarek E, Lee MH, McDonagh J. J Biol Chem; 1993 Feb 05; 268(4):2474-9. PubMed ID: 8428923 [Abstract] [Full Text] [Related]
2. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking. Achyuthan KE, Dobson JV, Greenberg CS. Biochim Biophys Acta; 1986 Aug 15; 872(3):261-8. PubMed ID: 2873839 [Abstract] [Full Text] [Related]
3. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator. Bakker AH, Nieuwenbroek NM, Verheijen JH. Protein Eng; 1995 Dec 15; 8(12):1295-1302. PubMed ID: 8869642 [Abstract] [Full Text] [Related]
4. Aggregated, conformationally changed fibrinogen exposes the stimulating sites for t-PA-catalysed plasminogen activation. Haddeland U, Sletten K, Bennick A, Nieuwenhuizen W, Brosstad F. Thromb Haemost; 1996 Feb 15; 75(2):326-31. PubMed ID: 8815585 [Abstract] [Full Text] [Related]
5. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E. Stewart RJ, Fredenburgh JC, Weitz JI. J Biol Chem; 1998 Jul 17; 273(29):18292-9. PubMed ID: 9660794 [Abstract] [Full Text] [Related]
6. Fibrin-mediated plasminogen activation. Nieuwenhuizen W. Ann N Y Acad Sci; 2001 Jul 17; 936():237-46. PubMed ID: 11460481 [Abstract] [Full Text] [Related]
8. Biochemical and functional characterization of human tissue-type plasminogen activator variants with mutagenized kringle domains. Collen D, Lijnen HR, Bulens F, Vandamme AM, Tulinsky A, Nelles L. J Biol Chem; 1990 Jul 25; 265(21):12184-91. PubMed ID: 2115513 [Abstract] [Full Text] [Related]
9. The position of the structurally autonomous kringle 2 domain influences the functional features of tissue-type plasminogen activator. Bakker AH, Rehberg EF, Marotti KR, Verheijen JH. Protein Eng; 1995 Mar 25; 8(3):293-300. PubMed ID: 7479691 [Abstract] [Full Text] [Related]
10. Evaluation of the factors contributing to fibrin-dependent plasminogen activation. Mosesson MW, Siebenlist KR, Voskuilen M, Nieuwenhuizen W. Thromb Haemost; 1998 Apr 25; 79(4):796-801. PubMed ID: 9569195 [Abstract] [Full Text] [Related]
11. Introduction of lysine and clot binding properties in the kringle one domain of tissue-type plasminogen activator. Bakker AH, van der Greef W, Rehberg EF, Marotti KR, Verheijen JH. J Biol Chem; 1993 Sep 05; 268(25):18496-501. PubMed ID: 8395505 [Abstract] [Full Text] [Related]
12. Sites in fibrin involved in the acceleration of plasminogen activation by t-PA. Possible role of fibrin polymerisation. Nieuwenhuizen W. Thromb Res; 1994 Aug 01; 75(3):343-7. PubMed ID: 7992246 [Abstract] [Full Text] [Related]
13. Study of tissue-type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogen. Grailhe P, Nieuwenhuizen W, Anglés-Cano E. Eur J Biochem; 1994 Feb 01; 219(3):961-7. PubMed ID: 8112348 [Abstract] [Full Text] [Related]
14. Glycated proteins modulate tissue-plasminogen activator-catalyzed plasminogen activation. Bobbink IW, Tekelenburg WL, Sixma JJ, de Boer HC, Banga JD, de Groot PG. Biochem Biophys Res Commun; 1997 Nov 26; 240(3):595-601. PubMed ID: 9398610 [Abstract] [Full Text] [Related]
15. The sequence A alpha-(154-159) of fibrinogen is capable of accelerating the t-PA catalysed activation of plasminogen. Schielen WJ, Adams HP, Voskuilen M, Tesser GI, Nieuwenhuizen W. Blood Coagul Fibrinolysis; 1991 Jun 26; 2(3):465-70. PubMed ID: 1932532 [Abstract] [Full Text] [Related]
16. A region of tissue plasminogen activator that affects plasminogen activation differentially with various fibrin(ogen)-related stimulators. Eastman D, Wurm FM, van Reis R, Higgins DL. Biochemistry; 1992 Jan 21; 31(2):419-22. PubMed ID: 1731899 [Abstract] [Full Text] [Related]
17. Structural features mediating fibrin selectivity of vampire bat plasminogen activators. Bringmann P, Gruber D, Liese A, Toschi L, Krätzchmar J, Schleuning WD, Donner P. J Biol Chem; 1995 Oct 27; 270(43):25596-603. PubMed ID: 7592732 [Abstract] [Full Text] [Related]
18. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA. Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H. J Clin Invest; 1989 Aug 27; 84(2):647-55. PubMed ID: 2503541 [Abstract] [Full Text] [Related]
19. Investigation of residues in the fibrin(ogen) gamma chain involved in tissue plasminogen activator binding and plasminogen activation. Wilhelm SE, Lounes KC, Lord ST. Blood Coagul Fibrinolysis; 2004 Sep 27; 15(6):451-61. PubMed ID: 15311153 [Abstract] [Full Text] [Related]
20. Identification and characterization of novel lysine-independent apolipoprotein(a)-binding sites in fibrin(ogen) alphaC-domains. Tsurupa G, Ho-Tin-Noé B, Anglés-Cano E, Medved L. J Biol Chem; 2003 Sep 26; 278(39):37154-9. PubMed ID: 12853452 [Abstract] [Full Text] [Related] Page: [Next] [New Search]